Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU4ATAC18P is a *pseudogene* of the RNA, U4atac small nuclear gene family[1]. It does not encode a functional small nuclear RNA. Functionally, it is classified as a non-coding RNA pseudogene, and there are no known direct biological roles or disease associations for this specific pseudogene. The parent gene family (RNU4ATAC) encodes U4atac snRNA, a component of the minor spliceosome essential for splicing of U12-type introns, and mutations in the functional RNU4ATAC gene have been linked to several severe developmental disorders[4]. However, for RNU4ATAC18P itself, there is no evidence that it is expressed or that it acts as a therapeutic target. Pseudogenes in general may exert regulatory effects, such as acting as competing endogenous RNAs or being processed into regulatory RNAs, but no such roles have been reported for RNU4ATAC18P[1][5]. **Note:** - As a *pseudogene*, RNU4ATAC18P is generally not considered a protein, enzyme, receptor, transporter, or direct therapeutic target[1][5]. - There appears to be nothing specifically wrong with the record, except that it *does not correspond to an actionable or canonical pharmacological target*; thus, **is_incorrect: true** (for the purpose of target lists). - The functional and disease information of the *functional gene* (RNU4ATAC) should not be ascribed to the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4atac small nuclear 18, pseudogene (RNU4ATAC18P).